| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Vrednotenje delnic ameriških in evropskih farmacevtskih podjetij
Authors:ID Robar, Klemen (Author)
ID Romih, Dejan (Mentor) More about this mentor... New window
Files:.pdf VS_Robar_Klemen_2023.pdf (2,02 MB)
MD5: 10F7B90639BD745B2994072CB3AE60A7
 
Language:Slovenian
Work type:Bachelor thesis/paper
Typology:2.11 - Undergraduate Thesis
Organization:EPF - Faculty of Business and Economics
Abstract:Problem, s katerim se vsak investitor sooča pred investiranjem denarja v neko delnico, je, da ne ve, katera investicija mu bo doprinesla največji dobiček na vložen kapital. V zaključnem delu raziskujemo, ali lahko s pomočjo najpogosteje uporabljenih kazalnikov za vrednotenje delnic predvidimo, katera investicija bo doprinesla največje donose. To smo analizirali tako, da smo primerjali donos dveh različnih portfeljev in industrijskih indeksov znotraj farmacevtskega sektorja v 10 letih investiranja s 5 najpogosteje uporabljenimi kazalniki. Ugotovili smo, da bi lahko s pomočjo teh kazalnikov predvideli, katera investicija bi nam doprinesla največji donos. Investitorjem svetujem, da uporabijo teh pet kazalnikov kot vodilo in pomoč pri izločevanju dobrih potencialnih investicij od slabih. Ne svetujemo, da se za odločitev o investiranju uporabi izključno teh 5 kazalnikov, saj je za dobro analizo investicij treba opraviti bolj podrobno analizo.
Keywords:delnica, farmacija, farmacevtsko podjetje, kazalnik, portfelj, vrednotenje delnice.
Place of publishing:Maribor
Publisher:K. Robar
Year of publishing:2023
PID:20.500.12556/DKUM-84586 New window
UDC:336.763.2
COBISS.SI-ID:164534275 New window
Publication date in DKUM:16.05.2024
Views:270
Downloads:86
Metadata:XML DC-XML DC-RDF
Categories:EPF
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:24.06.2023

Secondary language

Language:English
Title:Valuation of shares of american and european pharmaceutical companies
Abstract:The problem that every investor faces before investing money in a particular stock is that he does not know which investment will give him the highest return on his capital. In the last part of the study, we investigate whether we can predict which investment will bring the highest returns using the most commonly used indicators of stock valuation. To do this, we compared the returns of two different portfolios and sector indices in the pharmaceutical sector over a 10-year investment period using the 5 most commonly used indicators. We found that we could predict which investment would give us the highest returns using these indicators. We advise investors to use these five indicators as a guide and assistance to distinguish good potential investments from bad ones. However, we do not recommend relying solely on these 5 indicators to make investment decisions, as more detailed analysis is required for proper investment analysis.
Keywords:stock, pharmaceutical, pharmaceutical company, portfolio, stock valuation, indicators.


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica